- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03210610
Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients
April 18, 2018 updated by: Prof. Merav Lidar, Sheba Medical Center
Measurement of Colchicine Levels in the Serum of FMF Patients
in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken.
response to treatment, colchicine side effects and anthropometric data will be collected.
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: merav lidar, prof
- Phone Number: +972-3-5304413
- Email: merav.lidar@sheba.health.gov.il
Study Locations
-
-
-
Ramat Gan, Israel
- Recruiting
- Sheba Medical Center
-
Contact:
- merav lidar, prof
- Phone Number: +972-3-5304413
- Email: merav.lidar@sheba.health.gov.il
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
FMF patients treated with a constant dose of colchicine
Description
Inclusion Criteria:
- constant colchicine levels
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
FMF patients
fmf patients under a constant colchicine dose
|
levels of colchicine will be measured in FMF patients taking colchicine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
colchicine levels
Time Frame: a single measurement under a constant dosage at visit 1 (time=0, recruitment)
|
the trough level of colchicine in the serum
|
a single measurement under a constant dosage at visit 1 (time=0, recruitment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: merav lidar, prof, Sheba Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2017
Primary Completion (Anticipated)
July 15, 2020
Study Completion (Anticipated)
July 15, 2020
Study Registration Dates
First Submitted
June 29, 2017
First Submitted That Met QC Criteria
July 4, 2017
First Posted (Actual)
July 7, 2017
Study Record Updates
Last Update Posted (Actual)
April 20, 2018
Last Update Submitted That Met QC Criteria
April 18, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3997-17-SMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on FMF
-
Rambam Health Care CampusWithdrawnFamilial Mediterranean Fever (FMF )
-
Assistance Publique - Hôpitaux de ParisInstitut ImagineNot yet recruitingAutoinflammatory Disease | FMF | TRAPS | MKD | Cryopyrin Associated Periodic Syndrome | HaploinsufficiencyFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Istanbul University - Cerrahpasa (IUC)Recruiting
-
R-Pharm International, LLCAtlant Clinical LLC; Center for Pharmaceutical Analytics LLC; Unimed Laboratories... and other collaboratorsRecruitingFamilial Mediterranean Fever | FMFArmenia, Georgia, Russian Federation
-
R-Pharm International, LLCR-Pharm; Atlant Clinical LLC; Unimed Laboratories CJSC; Data Management 365; Center...RecruitingFamilial Mediterranean Fever | FMFArmenia, Georgia, Russian Federation
-
University of PalermoCompletedFamilial Mediterranean Fever (FMF) | Not-celiac Wheat Sensitivity (NCWS)Italy
-
National Human Genome Research Institute (NHGRI)Merck Sharp & Dohme LLC; Duke University; University of Massachusetts, WorcesterRecruitingFever | Genetic Diseases | Familial Mediterranean Fever (FMF) | Autoinflammation | Periodic Fever | ROSAH | ALPK1United States
Clinical Trials on colchicine level measurement
-
Medical University of GrazNot yet recruitingDelirium | Critical IllnessAustria
-
St. Petersburg State Pavlov Medical UniversityUnknownStroke | Carotid Artery DiseasesRussian Federation
-
University of Missouri-ColumbiaMassachusetts Institute of TechnologyCompletedOral Glucose Tolerance Test
-
Bassett HealthcareCompletedEarly Mobilization of Mechanically Ventilated PatientsUnited States
-
Aljazeera HospitalCairo University; National Research Centre, EgyptUnknown
-
Selcuk UniversityActive, not recruitingBruxism | Anxiety State | Tryptophan Metabolism AlterationsTurkey
-
Medical College of WisconsinRecruitingAdenocarcinoma EsophagusUnited States
-
Ankara Etlik City HospitalDiskapi Yildirim Beyazit Education and Research HospitalCompleted
-
Medical College of WisconsinWithdrawnRectal CancerUnited States